Boosting recovery after spinal cord injury: how engineered mitochondria are changing the game.

A new study published in ACS Nano highlights a promising advance in the treatment of spinal cord injury (SCI), using a novel approach centered around the body’s powerhouse, mitochondria.

Spinal cord injuries often cause lasting damage because the cells in the nervous system struggle to repair themselves, especially under the oxidative stress that follows injury. Mitochondrial transplantation, delivering healthy mitochondria into damaged cells, has been explored as a way to support cell repair. However, it has faced a major hurdle: mitochondria degrade too quickly to be effective for long.

That’s where HQ-Mitofactories come in.

Researchers developed these “high-quality mitochondria microfactories” by attaching Prussian blue nanoenzymes to stem cells. This combination creates a protective, energy-producing hub that not only shields mitochondria from oxidative stress but keeps generating new, functional ones over time. These engineered HQ-Mitofactories can then transfer healthy mitochondria directly to damaged neurons through tiny cell-to-cell connections known as gap junctions.

The results are striking. In mouse models of spinal cord injury, this approach led to significant recovery. Around 40% of mice treated with HQ-Mitofactories were able to walk again after complete hindlimb paralysis, a dramatic contrast to untreated mice, which showed no movement at all.

Visualizing mitochondria in action with MI-SIM imaging

A crucial part of this breakthrough was understanding what was happening inside the cells during treatment. This is where MI-SIM (Multi-Illumination Structured Illumination Microscopy) technology played a key role.

Using MI-SIM, researchers were able to visualize mitochondria in high resolution, even under oxidative stress. This allowed them to confirm that the transplanted mitochondria not only remained intact but also maintained the elongated, interconnected structures that are essential for healthy function.

These high-detail images confirmed that the HQ-Mitofactories weren’t simply delivering short bursts of energy. They were altering the mitochondrial landscape inside damaged neurons, restoring long-term function and promoting repair.

The impact on spinal cord injury treatment

This research offers a new direction in SCI treatment. Rather than relying on short-lived interventions, HQ-Mitofactories support the continuous generation of healthy mitochondria at the injury site, directly improving conditions for nerve cell repair.

It also demonstrates the role of high-resolution imaging tools like MI-SIM in advancing mitochondrial therapies. By making mitochondrial activity visible under oxidative stress, this technology enables researchers to fine-tune next-generation treatments that may eventually reach the clinic.

Read the full study: https://pubs.acs.org/doi/10.1021/acsnano.4c12557